ResMed Inc. vs Suncor Energy Inc. — how do they compare? ResMed Inc. trades at $230.12 (market cap $31.89B), while Suncor Energy Inc. trades at $72.18 (market cap $82.76B). The key difference: Suncor Energy Inc. is far larger — about 2.6× ResMed Inc.'s market cap, and Suncor Energy Inc. pays the higher dividend (2.39%). Which is the better fit depends on your goals — on Pluang, investors hold ResMed Inc. for 51 Days and Suncor Energy Inc. for 57 Days on average.
| RMD | SU | |
|---|---|---|
Market Cap | $31.89B | $82.76B |
Volume | 618,314 | 3,832,959 |
Sector | Health | Energy |
52-Week High | $277.88 | $71.87 |
52-Week Low | $182.82 | $38.17 |
Typical Hold Time | 51 Days | 57 Days |
Enterprise Value | $31.24B | $89.29B |
Dividend Yield | 1.16% | 2.39% |
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $230.91, up 2.18% today, with a bullish technical signal and strong fundamentals. The company reported consistent earnings beats in recent quarters, with Q3 2026 EPS expected at $2.68. Revenue grew to $5.15B in 2025, with a net income margin of 26.94%. Analyst consensus is a buy, with a $242.70 price target. Recent news highlights EPS growth targets of 12%-14% and participation in investor conferences.
Outlook is positive due to robust earnings growth and market share gains, but risks include competitive pressures and regulatory investigations. The stock offers upside to the consensus target, supported by institutional buying and solid cash flow generation.
Suncor Energy (SU) trades at $72.23, up 6.0% today and near its 52-week high, reflecting strong momentum. The stock shows bullish technical signals with moving averages supporting further upside, while fundamentals indicate solid profitability with a 14.7% net income margin and attractive valuation at a P/E of 13.46. Recent Q2 2026 earnings beat expectations, and the company is boosting shareholder returns through buybacks and a $0.60 dividend.
The outlook remains positive given robust cash flow, debt reduction, and strategic asset sales, but risks include commodity price volatility and operational disruptions. With 74% analyst buy ratings and institutional confidence, SU offers value in the energy sector, though investors should monitor execution under new leadership and macroeconomic pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →